drugset / Trial / NCT00794885

China Stroke Primary Prevention Trial

NCT00794885 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this trial is to confirm that enalapril maleate and folic acid tablets is more effective in preventing stroke among the patients with primary hypertension when compared to enalapril maleate.

Timeline

Start
2008-05
Primary completion
2013-08
Completion
2014-06

Outcome

Met primary endpoint

paper first stroke (2.7% of participants in the enalapril-folic acid group vs 3.4% in the enalapril alone group; hazard ratio [HR], 0.79 PMID 25771069 ↗

paper the combined use of enalapril and folic acid, compared with enalapril alone, significantly reduced the risk of first stroke. PMID 25771069 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject folic acid Other / unclassified 0.8 mg Oral
Comparator Enalapril Other / unclassified 10 mg Oral